
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
Boehringer Ingelheim applied for Food and Drug Administration approval in late October of its protease inhibitor Tipranavir. A decision could come by the end of April. The company also filed for European Union approval. Boehringer Ingelheim launched an Expanded Access Program in November for Tipranavir while the drug is under review by the FDA. Indian drug firm Ranbaxy plans to submit three drugs'two different fixed-dose generic combinations of Epivir, Zerit, and Viramune and a two-drug combination pill of Epivir and Retrovir'to the FDA so the drugs can be purchased for the President's Emergency Plan for AIDS Relief. OraSure Technologies began a nationwide launch in November of its OraQuick Advance Rapid HIV-1/2 Antibody Test, which can produce results in about 20 minutes. Gilead Sciences halted production in October of two experimental anti-HIV drugs, protease inhibitor GS 9005 and nucleoside reverse transcriptase inhibitor GS 7340. GS 9005 was shown to have insufficient antiviral activity; GS 7340 was found to be too similar to existing drug Viread. Roche announced in November that it will not introduce its 625-milligram formulation of Viracept in Europe because of production problems. Company officials say they had difficulty making the film coating for the tablets. The 625-milligram version is marketed by Pfizer in the United States. Bristol-Myers Squibb wrote to U.S. health care providers in November to warn them of early virologic failure in treatment-naive patients who begin antiretroviral therapy with regimens that combine its drug Videx EC and Gilead Sciences' Viread with either the BMS drug Sustiva or with Boehringer Ingelheim's Viramune. Early drug failure was most common in patients with high baseline viral loads. A study presented at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy has shown that simultaneous administration of protease inhibitors Invirase and a booster dose of Norvir is needed for optimal Invirase absorption. Researchers reported at the 44th ICAAC that protease inhibitor Kaletra can deteriorate in hot climates. At 35 degrees Celsius (95 degrees Fahrenheit), Kaletra capsules became misshapen and drug content fell below 85% after 60 days. Changes were noticed within one day at 45 degrees Celsius (113 degrees Fahrenheit). A study in the online edition of Public Library of Science Medicine has shown that Viramune leads to higher increases in 'good' cholesterol than either Sustiva or lipid-controlling statin drugs. A study in the December 15 edition of The Journal of Infectious Diseases has shown that Zerit is safe and effective in preventing vertical HIV transmissions when given to pregnant women and their newborns. Researchers at the University of Buffalo have reported that the nucleotide reverse transcriptase inhibitor Viread does not alter the pharmacokinetics of methadone when given to recovering injection-drug users. A study presented at the Seventh International Congress on Drug Therapy in HIV Infection has suggested that HIV-positive children have better clinical outcomes and do not experience liver complications when treated with higher than recommended doses of Viramune. A study reported by Abbott Laboratories in November has shown that no primary protease inhibitor resistance was detected in any patient taking Kaletra for 300 weeks. Researchers reported in the September issue of Journal of Medical Virology that treatment with Fuzeon can hold CD4-cell counts steady or produce CD4-cell increases even when HIV viral loads remain high. A study released in October by Gilead Sciences has shown that treatment-naive HIV patients treated with a once-daily regimen of Viread, Emtriva, and Sustiva experienced fewer adverse side effects than those taking a regimen of twice-daily Combivir and once-daily Sustiva. Researchers reported at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy that a regimen of the three-in-one-pill Trizivir is as effective as regimens containing Combivir and Viramune. A study presented at the 44th ICAAC has shown that short-term treatment with Reyataz results in fewer metabolic disturbances than Kaletra therapy. U.K. drug regulators released a warning in November that taking protease inhibitors or antifungal agents along with lipid-lowering statin drugs, particularly Zocor and Lipitor, can boost risks for life-threatening muscle toxicity. Researchers at the University of Alabama have reported that once-weekly treatment with epoetin alfa'a synthetic protein sold as Procrit by Ortho Biotech Products and Epogen by Amgen'can boost hemoglobin levels and improve quality of life factors for HIV-positive adults experiencing anemia. A study presented at the Seventh International Congress on Drug Therapy in HIV Infection has shown that patients treated with the anabolic steroid Nandrolone experienced modest improvements in symptoms of HIV-related wasting.
From our Sponsors
Most Popular
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
Grindr is reminding us why jockstraps are so sexy and iconic
May 02 2025 5:36 PM
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
Plus: Featured Video
Latest Stories
Trump admin guts $258 million in funding for HIV vaccine research
June 03 2025 3:47 PM
HRC holds 'die-in' to protest Trump health care cuts
April 28 2025 2:11 PM
Two right-wing Supreme Court justices signal they may uphold access to PrEP and more
April 21 2025 4:10 PM
500,000 Children at Risk: PEPFAR Funding Crisis
April 08 2025 3:51 PM
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Decades of progress, uniting to fight HIV/AIDS
December 01 2024 12:30 PM
Hollywood must do better on HIV representation
December 01 2024 9:00 AM
Climate change is disrupting access to HIV treatment
November 25 2024 11:05 AM
California confirms first case of even more deadly mpox strain
November 18 2024 3:02 PM